Premium
Patient monitoring: the hidden costs of treatment with antipsychotics
Author(s) -
Nederlof Mariëtte,
Frederix Geert W. J.,
Stoker Lennart J.,
Solinge Wouter W.,
Egberts Toine C. G.,
Heerdink Eibert R.
Publication year - 2016
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.12982
Subject(s) - medicine , antipsychotic , summary of product characteristics , population , therapeutic drug monitoring , intensive care medicine , schizophrenia (object oriented programming) , authorization , atypical antipsychotic , drug , medical emergency , psychiatry , environmental health , computer security , computer science
Antipsychotics are an important and frequently used treatment option for patients with schizophrenia. During treatment patients need to be monitored to determine effectiveness and safety, therefore total drug treatment costs also include the costs of patient monitoring. In this study we assess the proportion of patient monitoring as a part of antipsychotic treatment costs in patients with schizophrenia.